NasdaqCM - Nasdaq Real Time Price USD
Jasper Therapeutics, Inc. (JSPR)
4.7000
+0.1400
+(3.07%)
As of 12:34:22 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CARLYLE GROUP, INC. Unknown | Purchase | Feb 8, 2024 | -- |
| LIS WILLIAM DAVID Director | Sale | Oct 13, 2023 | 53,521 |
| MAHAL JEETINDER SINGH Chief Operating Officer | Conversion of Exercise of derivative security | Dec 12, 2024 | 25,009 |
| TUCKER EDWIN JONATHAN Officer | Stock Award(Grant) | Jun 7, 2024 | 400 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 8, 2024 | -- |
| WIGGANS THOMAS G Director | Purchase | Nov 28, 2023 | 50,000 |
Related Tickers
TIL Instil Bio, Inc.
19.64
-4.29%
ADIL Adial Pharmaceuticals, Inc.
0.7010
-3.84%
LCTX Lineage Cell Therapeutics, Inc.
0.4700
-0.42%
BCYC Bicycle Therapeutics plc
8.45
-2.55%
PTGX Protagonist Therapeutics, Inc.
45.44
-1.57%
ACRV Acrivon Therapeutics, Inc.
1.9194
-4.03%
RLMD Relmada Therapeutics, Inc.
0.6653
-3.58%
NMRA Neumora Therapeutics, Inc.
0.7480
+5.22%
TARA Protara Therapeutics, Inc.
4.2000
0.00%
PYXS Pyxis Oncology, Inc.
1.0850
+0.46%